Concepedia
Statistics
Publications
25
Citations
4.4K
H-Index
17
Active since
1964
Affiliations
Gilead Sciences (United States)(Current)
Inserm
Henry Dunant Hospital
University of Miami
Hammersmith Medicines Research
John Fry is an author at Gilead Sciences (United States) specializing in antiviral therapy, pharmacy, and molecular virology.
Publications per year
1964–2018
Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis B
Patrick Marcellin, Ting‐Tsung Chang, Seng Gee Lim et al. · New England Journal of Medicine · 2003 · 1.3K citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +14
Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B
Stephanos J. Hadziyannis, Nicolaos C. Tassopoulos, E. Jenny Heathcote et al. · New England Journal of Medicine · 2003 · 999 citations · Full text
Adefovir Dipivoxil Therapy for Lamivudine–Resistant Hepatitis B in Pre- and Post-Liver Transplantation Patients
Eugene R. Schiff, Ching‐Lung Lai, Stefanos J. Hadziyannis et al. · Hepatology · 2003 · 365 citations
Pharmacy, Infectious Diseases, Pharmacotherapy +17
Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study
Y. Benhamou, Marie-Valérie Bochet, Vincent Thibault et al. · The Lancet · 2001 · 315 citations
Medicine, Infectious Diseases, Pharmacology +16
Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study
John P. DeVincenzo, Matthew W. McClure, Julian Symons et al. · New England Journal of Medicine · 2015 · 229 citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +15
1–5 of 25